The European Medicines Agency will convene a meeting on Dec. 29 to decide if there is enough data about the safety and efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech for it to be approved, the regulator said Tuesday.
Traveling, dining out and holiday parties might not the best idea this year as the world grapples with the coronavirus pandemic, but there are still plenty of fun ways you and your family can enjoy this winter season.
The coronavirus vaccine inching toward approval in the U.S. is desperately anticipated by weary Americans longing for a path back to normal life. But criminals are waiting, too, ready to use that desperation to their advantage, federal investigators say.
The coronavirus testing numbers that have guided much of the nation’s response to the pandemic are likely to be erratic over the next week or so, experts said Friday, as fewer people get tested during the Thanksgiving holiday weekend and testing sites observe shorter hours.
It’s another layer of the “tremendous stress” faced by administrators and educators navigating the pandemic, said Dan Domenech, executive director of AASA, the nation’s leading school superintendents association.
Millions of Americans took to the skies and the highways ahead of Thanksgiving at the risk of pouring gasoline on the coronavirus fire, disregarding increasingly dire warnings that they stay home and limit their holiday gatherings to members of their own household.
Federal officials say national reading and math tests used to track what U.S. students know are being postponed from next year to 2022 over concerns about whether such testing would be feasible or produce valid results amid the pandemic.
AstraZeneca is the third major drug company to report late-stage results for a potential COVID-19 vaccine as the world anxiously waits for scientific breakthroughs that will bring an end to a pandemic that has wrought economic devastation and resulted in nearly 1.4 million confirmed deaths.
With El Paso hospitals and ICUs over capacity since last month due to one of the worst COVID-19 surges in the country, three Air Force medical teams have spent the past two weeks deployed to aid in the fight.
U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month.